31/23/31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/23/03 GSK Nigeria calls an end to its business, to return cash RE
03/23/03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/23/03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/22/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/22/29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/22/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/22/31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/21/25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/21/29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 01/08/2011
General Counsel - 01/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.28Cr
-1.60%+2.02%+56.34%+168.94% 1,08400Cr
-1.44%+3.71%+69.07%+65.40% 63TCr
-0.75%+0.67%+33.18%+86.52% 45TCr
-0.40%-2.40%+28.19%+25.66% 33TCr
-9.33%-11.53%+24.13%+26.35% 30TCr
-0.51%-2.19%+28.36%+45.98% 28TCr
-0.62%-3.09%-27.38%-39.40% 22TCr
-0.03%+1.84%+23.90%+68.30% 20TCr
-0.40%+7.82%+22.29%+82.50% 17TCr
Average -1.52%+2.52%+28.68%+58.92% 40.67TCr
Weighted average by Cap. -1.71%+2.48%+40.09%+85.11%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock